Tronox Holdings plc (NYSE: TROX) is a Basic Materials company in the Chemicals industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -3.46 | Insider Own | 5.96% | Shs Outstand | 159.52M | Perf Week | -4.75% |
| Market Cap | 671.60M | Forward P/E | - | EPS next Y | -0.36 | Insider Trans | 0.00% | Shs Float | 118.68M | Perf Month | -26.53% |
| Enterprise Value | 3.85B | PEG | 0.02 | EPS next Q | -0.16 | Inst Own | - | Short Float | 16.83% | Perf Quarter | -43.11% |
| Income | -547.89M | P/S | 0.22 | EPS this Y | 59.83% | Inst Trans | - | Short Ratio | 7.53 | Perf Half Y | -42.88% |
| Sales | 3.05B | P/B | 0.58 | EPS next Y | 74.34% | ROA | -9.23% | Short Interest | 19.97M | Perf YTD | 0.96% |
| Book/sh | - | P/C | 6.66 | EPS next 5Y | - | ROE | -40.45% | 52W High | 10.59 -60.25% | Perf Year | -15.29% |
| Cash/sh | - | P/FCF | - | EPS past 3/5Y | - | ROIC | -2.08% | 52W Low | 2.86 47.20% | Perf 3Y | -68.58% |
| Dividend Est. | 0.20 (4.75%) | EV/EBITDA | 43.73 | Sales past 3/5Y | -5.80% 0.92% | Gross Margin | 5.34% | Volatility | 3.93% 4.59% | Perf 5Y | -79.50% |
| Dividend TTM | 0.20 (4.75%) | EV/Sales | 1.26 | EPS Y/Y TTM | -1053.33% | Oper. Margin | -3.54% | ATR (14) | 0.27 | Perf 10Y | -54.24% |
| Dividend Ex-Date | Aug 10, 2026 | Quick Ratio | 0.81 | Sales Y/Y TTM | -0.72% | Profit Margin | -17.99% | RSI (14) | 24.16 | Recom | 2.82 |
| Dividend Gr. 3/5Y | -11.21% 4.56% | Current Ratio | 2.55 | EPS Q/Q | -82.14% | SMA20 | -13.99% | Beta | 0.89 | Target Price | 8.08 |
| Payout | -8.01% | Debt/Eq | 2.90 | Sales Q/Q | 18.74% | SMA50 | -24.94% | Rel Volume | 1.94 | Prev Close | 4.27 |
| Employees | 5,700 | LT Debt/Eq | 2.37 | Earnings | Nov 04 | SMA200 | -37.89% | Avg Volume | 2.63M | Price | 4.21 |
| IPO Date | Dec 01, 2010 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -34.81% 4.25% | Net Debt/EBITDA | 36.10 | Volume | 5,107,451 | Change | -1.41% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-13-26 | Reiterated | China Renaissance Securities (US) Inc. | $5.00 | |
| Aug-13-26 | Downgrade | JP Morgan | Neutral → Underweight | |
| Jul-22-26 | Reiterated | Goldman Sachs | Sell | $9.00 → $6.50 |
| Jun-11-26 | Upgrade | Truist Securities | Sell → Hold | |
| May-20-26 | Reiterated | Deutsche Bank | Buy | $11 → $10 |
| May-12-26 | Downgrade | Goldman Sachs | Buy → Sell | $7.50 → $9.00 |
| May-07-26 | Reiterated | Fermium Research | $9.00 | |
| Apr-28-26 | Downgrade | Truist Securities | Hold → Sell | |
| Apr-09-26 | Reiterated | UBS | Neutral | $5.25 → $9.00 |
| Apr-09-26 | Downgrade | Truist Securities | Buy → Hold | $8.00 → $9.00 |
Tronox Holdings plc functions as a globally integrated producer of titanium dioxide (TiO2) pigment, maintaining a significant presence across North and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company's operations span the entire value chain, beginning with the mining of titanium-bearing mineral sands and extending through beneficiation and smelting processes. Its extensive product range includes various forms of TiO2 pigment, such as ultrafine specialty TiO2, alongside zircon, feedstock materials, pig iron, titanium tetrachloride, and other associated products. These essential materials are utilized in the manufacturing of paints, coatings, plastics, and paper, as well as numerous other industrial applications. Tronox Holdings plc is headquartered in Stamford, Connecticut.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,052 | 2,887 | 3,074 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,889 | 2,658 | 2,559 | — | — | — | — | — | — | |
| Gross Profit | 163 | 229 | 515 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 267 | 244 | 251 | — | — | — | — | — | — | |
| Research and Development | 0 | 15 | 14 | — | — | — | — | — | — | |
| Other Operating Expense | 4 | 0 | 31 | — | — | — | — | — | — | |
| Operating Income | -108 | -30 | 219 | — | — | — | — | — | — | |
| Interest Expense | 211 | 189 | 167 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -123 | -239 | 21 | — | — | — | — | — | — | |
| Net Income Before Taxes | -442 | -458 | 73 | — | — | — | — | — | — | |
| Income Taxes | 112 | 15 | 127 | — | — | — | — | — | — | |
| Consolidated Net Income | -549 | -470 | -48 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | -554 | -473 | -54 | — | — | — | — | — | — | |
| Net Income | -549 | -470 | -48 | — | — | — | — | — | — | |
| EPS (Recurring) | -3.46 | -2.97 | -0.30 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -3.46 | -2.97 | -0.30 | — | — | — | — | — | — | |
| EPS (Diluted) | -3.46 | -2.97 | -0.30 | — | — | — | — | — | — | |
| EBITDA | 88 | 54 | 525 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.22 | 0.23 | 0.52 | — | — | — | — | — | — | |
| Gross Margin | 5.34 | 7.93 | 16.75 | — | — | — | — | — | — | |
| Operating Margin | -3.54 | -1.04 | 7.12 | — | — | — | — | — | — | |
| Net Margin | -17.99 | -16.28 | -1.56 | — | — | — | — | — | — | |
| Shares Outstanding | 160 | 158 | 158 | — | — | — | — | — | — | |
| Market Capitalization | 674 | 659 | 1,591 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Romano John D | CEO and Director | Mar 06 '26 | Sale | 6.59 | 101,600 | 669,635 | 1,473,740 | Mar 09 |
| Srivisal John | SVP, Chief Financial Officer | Mar 06 '26 | Sale | 6.59 | 19,461 | 128,297 | 279,677 | Mar 09 |
| Turgeon Jean Francois | Director | Mar 06 '26 | Sale | 6.60 | 18,563 | 122,488 | 754,009 | Mar 09 |
| Neuman Jeffrey N | SVP, General Counsel & Sec. | Mar 06 '26 | Sale | 6.59 | 22,965 | 151,443 | 248,831 | Mar 09 |
| Engle Jeffrey A. | SVP, Chief Commercial Officer | Mar 06 '26 | Sale | 6.60 | 14,575 | 96,137 | 175,251 | Mar 09 |
| Flood Jonathan | Principal Accounting Officer | Mar 06 '26 | Sale | 6.58 | 8,008 | 52,729 | 92,861 | Mar 09 |
| Flood Jonathan | Principal Accounting Officer | Mar 05 '26 | Sale | 7.55 | 7,000 | 52,852 | 100,869 | Mar 09 |
| Johnston Peter | Director | Aug 12 '25 | Buy | 3.21 | 20,000 | 64,200 | 191,513 | Aug 13 |
| Turgeon Jean Francois | Director | Aug 07 '25 | Buy | 3.21 | 31,150 | 100,027 | 772,572 | Aug 08 |
| Jones Stephen J | Director | Aug 07 '25 | Buy | 3.19 | 8,000 | 25,480 | 51,000 | Aug 07 |
| Jones Stephen J | Director | Aug 06 '25 | Buy | 3.20 | 7,000 | 22,379 | 43,000 | Aug 07 |
| Jones Stephen J | Director | Aug 05 '25 | Buy | 3.32 | 6,000 | 19,920 | 36,000 | Aug 06 |
| Srivisal John | SVP, Chief Financial Officer | Aug 01 '25 | Buy | 3.39 | 37,000 | 125,478 | 237,283 | Aug 01 |
| Engle Jeffrey A. | SVP, Commercial and Strategy | Aug 01 '25 | Buy | 3.07 | 12,600 | 38,682 | 146,926 | Aug 01 |
| Romano John D | CEO and Director | Aug 01 '25 | Buy | 3.09 | 100,000 | 308,930 | 1,333,485 | Aug 01 |